Yahoo Web Search

Search results

1. pubmed.ncbi.nlm.nih.gov › 33849780Efficacy of mepolizumab in elderly patients with severe ...

   pubmed.ncbi.nlm.nih.gov › 33849780

   Conclusions: Mepolizumab may be effective in elderly patients with eosinophilic asthma and ACO. Keywords: Asthma and chronic obstructive pulmonary disease overlap; Elderly patient; Eosinophil; Interleukin-5; Severe asthma.

   • Switching Treatment from Mepolizumab to Benralizumab for ...

     We enrolled 12 elderly patients (age ≥65 years) with severe...

   • Long-Term Safety and Effectiveness of Diquafosol for the ...

     Diquafosol is a P2Y 2 receptor agonist that is approved for...

2. www.nomuraholdings.com › company › groupLeadership Team | NOMURA

   www.nomuraholdings.com › company › group

   • Cached

   Jun 5, 2024 · Leadership Team. Senior Managing Directors include Executive Managing Directors and Senior Managing Directors of Nomura Holdings, Nomura Securities SMDs, as well as group SMDs appointed by the Nomura Holdings Executive Management Board. As of June 5, 2024.

   Name	Position
   Kentaro Okuda	President and Group CEO of Nomura ...
   Tomoyuki Teraguchi	Vice Chairman of Nomura Holdings, Inc.
   Yutaka Nakajima	Representative Executive Officer, Deputy ...
   Toshiyasu Iiyama	Executive Officer, Deputy President of ...

   See full list on nomuraholdings.com

3. www.ncbi.nlm.nih.gov › pmc › articlesSwitching Treatment from Mepolizumab to Benralizumab for ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jun 6, 2022 · We enrolled 12 elderly patients (age ≥65 years) with severe eosinophilic asthma treated with mepolizumab at Hiroshima Prefectural Hospital (Hiroshima, Japan) during the study period. Six patients were switched from mepolizumab to benralizumab, and six continued with the mepolizumab treatment.

   • DOI: 10.2169/internalmedicine.8180-21
   • Published: 2022/06/06

   • Publication: Intern Med. 2022 Jun 1; 61(11): 1663-1671.

4. boardgamewire.com › index › 2024/04/26CMON buys Japon Brand, the company which introduced the world ...

   boardgamewire.com › index › 2024/04/26

   • Cached

   Apr 26, 2024 · Akio Nomura, a long-time board game designer and board member of Japon Brand, becomes president of the company following the buyout. He said, “The situation surrounding the analogue game industry in Japan has been changing over the past ten years.

5. www.ncbi.nlm.nih.gov › pmc › articlesLong-Term Safety and Effectiveness of Diquafosol for the ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Dec 13, 2019 · Diquafosol is a P2Y 2 receptor agonist that is approved for the treatment of dry eye disease (DED) in Japan. Short-term treatment with diquafosol was effective and safe in a prospective, observational, post-marketing study.

   • Author: Yuichi Ohashi, Masahiro Munesue, Jun Shimazaki, Etsuko Takamura, Norihiko Yokoi, Hitoshi Watanabe, A...
   • DOI: 10.1007/s12325-019-01188-x

   • Publish Year: 2020
   • Publication: Adv Ther. 2020; 37(2): 707-717.

6. pubmed.ncbi.nlm.nih.gov › 35650114Switching Treatment from Mepolizumab to Benralizumab for ...

   pubmed.ncbi.nlm.nih.gov › 35650114

   Jun 2, 2022 · Abstract. Objective Switching from mepolizumab to benralizumab has been reported to significantly improve both asthma control and the lung function. However, the data on its efficacy in elderly patients with severe eosinophilic asthma are limited.

7. www.sciencedirect.com › science › articleEfficacy of mepolizumab in elderly patients with severe ...

   www.sciencedirect.com › science › article

   Jul 1, 2021 · Thirty-three elderly patients (aged ≥65 years), diagnosed with severe eosinophilic asthma and treated at Hiroshima Prefectural Hospital (Hiroshima, Japan) between August 2016 and March 2019, were identified.